abstract
- Background: CD-NP, a chimeric natriuretic peptide, with veno-arterial vasodilation may simultaneously unload the heart and kidney in acute decompensated failure (ADHF) patients. This dose-ranging study investigated the safety and tolerability of CD-NP in ADHF patients (pts).